Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac for Inflammation and Pain in Cataract Surgery
NCT00521456Phase 3Completed
- Sponsor
- Allergan
- Start
- Oct 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ocular inflammation comparing Ketorolac with Placebo (2 arms). Primary endpoint: Resolution of Post Operative Inflammation at Day 14. Started Oct 2007; status: completed.
02
Drugs
ketorolac tromethamine
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT00521456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00521456.